Clinical Trials
74 trialsSAVED LUNG
Centre hospitalier de l'Université de Montréal (CHUM)
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
salVage
Swiss Cancer Institute
GIVEN
Guangdong Provincial People's Hospital
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
University of Iowa
STRADOS
Aarhus University Hospital
N-PLANC
Mayo Clinic
InDuRanS
University Hospital, Bonn
BOOST
Pusan National University Hospital
Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function
Lithuanian University of Health Sciences
Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Fondazione Ricerca Traslazionale
SURGAN-TKI
The First Affiliated Hospital of Guangzhou Medical University
ADDRESS
The First Affiliated Hospital of Guangzhou Medical University
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC)
Shanghai Chest Hospital
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Alliance Foundation Trials, LLC.
AEGEAN
AstraZeneca
ACCESS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC
Tianjin Medical University Cancer Institute and Hospital
CROWD
Amsterdam UMC, location VUmc
Pulmonary Rehabilitation Before Lung Cancer Resection
Alliance for Clinical Trials in Oncology
POSTILV
Radiation Therapy Oncology Group
HAMLET
Erasmus Medical Center
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
University of California, San Francisco
MLA-MNSCLCNET
Nanchang University
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
Ruijin Hospital
Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer
West China Hospital
PILOT
The Affiliated Hospital of Qingdao University
PITHAC
Centre Hospitalier Universitaire Vaudois
Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial
Shanghai Pulmonary Hospital, Shanghai, China
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Swiss Cancer Institute
Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial
Shanghai Pulmonary Hospital, Shanghai, China
A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
INNWOP1
Medical University Innsbruck
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
Radiation Therapy Oncology Group
NATCH
Spanish Lung Cancer Group
Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)
National Cancer Center Hospital East
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Swiss Cancer Institute
PIONEER
The Christie NHS Foundation Trust
NEOSUN
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
STARS
Accuray Incorporated
Neoafa
Fifth Affiliated Hospital, Sun Yat-Sen University
DEEP_OCEAN
National Cancer Center Hospital East
Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC
Eli Lilly and Company
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
The First Affiliated Hospital of Guangzhou Medical University
Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
Swiss Cancer Institute
Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer
Shanghai 10th People's Hospital